tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
Advertisement

Kymera Therapeutics (KYMR) Technical Analysis

Compare
357 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Kymera Therapeutics’s (KYMR) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Kymera Therapeutics is a Sell.
Kymera Therapeutics’s (KYMR) 20-Day exponential moving average is 42.35, while Kymera Therapeutics’s (KYMR) share price is $42.2, making it a Sell.
Kymera Therapeutics’s (KYMR) 50-Day exponential moving average is 42.23, while Kymera Therapeutics’s (KYMR) share price is $42.2, making it a Sell.

Kymera Therapeutics (KYMR) Pivot Points

Sep 06, 2025, 08:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
37.79
38.95
41.12
42.28
44.45
45.61
47.78
Fibonacci
38.95
40.22
41.00
42.28
43.55
44.33
45.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kymera Therapeutics (KYMR) Moving Averages

Sep 06, 2025, 08:55 AM
Period
Simple
Exponential
MA5
41.83Buy
42.17Buy
MA10
42.38Sell
42.19Buy
MA20
41.81Buy
42.35Sell
MA50
43.51Sell
42.23Sell
MA100
39.44Buy
40.88Buy
MA200
38.53Buy
40.95Buy
Kymera Therapeutics’s (KYMR) 10-Day exponential moving average is 42.19, while Kymera Therapeutics’s (KYMR) share price is $42.2, making it a Buy.
Kymera Therapeutics’s (KYMR) 100-Day exponential moving average is 40.88, while Kymera Therapeutics’s (KYMR) share price is $42.2, making it a Buy.
Kymera Therapeutics’s (KYMR) stock price is $42.2 and Kymera Therapeutics’s (KYMR) 50-day simple moving average is 43.51, creating a Sell signal.
Kymera Therapeutics’s (KYMR) stock price is $42.2 and Kymera Therapeutics’s (KYMR) 100-day simple moving average is 39.44, creating a Buy signal.
Kymera Therapeutics’s (KYMR) stock price is $42.2 and Kymera Therapeutics’s (KYMR) 200-day simple moving average is 38.53, creating a Buy signal.

Kymera Therapeutics (KYMR) Technical Indicators

Sep 06, 2025, 08:55 AM
Name
Value
Implied Action
RSI (14)
49.03
Neutral
STOCH (9,6)
47.71
Neutral
STOCHRSI (14)
48.43
Neutral
MACD (12,26)
-0.26
Sell
ADX (14)
14.70
Buy
Williams %R
-49.36
Buy
CCI (14)
21.20
Neutral
ATR (14)
2.03
-
Ultimate Oscillator
57.51
Neutral
ROC
1.56
Buy
Kymera Therapeutics’s (KYMR) Relative Strength Index (RSI) is 49.03, creating a Neutral signal.
Kymera Therapeutics’s (KYMR) Trend Strength Indicator (ADX) is 14.70, creating a Buy signal.
Kymera Therapeutics’s (KYMR) Commodity Channel Index (CCI) is 21.20, creating a Neutral signal.
Kymera Therapeutics’s (KYMR) Price Rate of Change (ROC) is 1.56, creating a Buy signal.

FAQ

Is KYMR a Buy, Hold, or Sell?
Based on KYMR’s technical indicators, KYMR is a Buy.
    What is KYMR’s RSI (14)?
    KYMR’s RSI (14) is 49.03, which suggests KYMR is a Neutral.
      What is KYMR’s MACD?
      KYMR’s MACD is -0.26, which suggests KYMR is a Sell.
        What is KYMR’s 5-day moving average?
        KYMR’s 5-day moving average is 41.83, which suggests KYMR is a Buy.
          What is KYMR’s 20-day moving average?
          KYMR 20-day moving average is 41.81, which suggests KYMR is a Buy.
            What is KYMR’s 50-day moving average?
            KYMR’s 50-day moving average is 43.51, which suggests KYMR is a Sell.
              What is KYMR’s 200-day moving average?
              KYMR’s 200-day moving average is 38.53, which suggests KYMR is a Buy.
                What is KYMR’s Williams % R (14)?
                KYMR’s Williams % R (14) is -49.36, which suggests KYMR is a Buy.
                  What is KYMR’s CCI (14)?
                  KYMR’s CCI (14) is 21.20, which suggests KYMR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis